PolyU develops novel antibody targeting fat cell protein, offering new approach to treating metabolism-related liver cancer (IMAGE)
Caption
FABP4 deficiency delayed the onset of tumor development in DEN-injected and HFD-induced MASLD-HCC mouse model.
Credit
polyu
Usage Restrictions
nil
License
Original content